Hereditary Transthyretin Amyloidosis: How to Differentiate Carriers and Patients Using Speckle-Tracking Echocardiography.

Daniela Di Lisi Filippo BrighinaGirolamo MannoFrancesco ComparatoVincenzo Di StefanoFrancesca MacaioneGiuseppe DamerinoLeandro Di CaccamoNoemi CannizzoAntonella OrtelloAlfredo R GalassiGiuseppina Novo

Published in: Diagnostics (Basel, Switzerland) (2023)

Our study suggests the diagnostic role of the SAB and RAS in cardiac amyloidosis. The SAB and RAS showed a gradual increase from carriers to patients with neurological and cardiac diseases. Thus, these parameters, in addition to atrial stiffness, could be used to monitor carriers. More extensive data are needed.

Keyphrases

left ventricular
wild type
end stage renal disease
ejection fraction
newly diagnosed
multiple myeloma
prognostic factors
pulmonary hypertension
atrial fibrillation
electronic health record
big data
artificial intelligence